Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

60 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Single-cell Atlas of Penile Cancer Reveals TP53 Mutations as a Driver of an Aggressive Phenotype, Irrespective of Human Papillomavirus Status, and Provides Clues for Treatment Personalization.
Elst L, Philips G, Vandermaesen K, Bassez A, Lodi F, Vreeburg MTA, Brouwer OR, Schepers R, Van Brussel T, Mohanty SK, Parwani AV, Spans L, Vanden Bempt I, Jacomen G, Baldewijns M, Lambrechts D, Albersen M. Elst L, et al. Among authors: baldewijns m. Eur Urol. 2024 Apr 25:S0302-2838(24)02266-8. doi: 10.1016/j.eururo.2024.03.038. Online ahead of print. Eur Urol. 2024. PMID: 38670879
Ultrastaging of sentinel lymph nodes in gynecological cancer: Repeating the story of breast cancer? Letter to the editor, Reply to Cibula D, McCluggage WG. Sentinel lymph node (SLN) concept in cervical cancer: Current limitations and unanswered questions. Gynecol Oncol 2019;152:202-7.
Colpaert C, Jacomen G, Van de Vijver K, Baldewijns M, Van Rompuy AS, Bourgain C, Noël JC; Belgian Working Group for Gynecological Pathology. Colpaert C, et al. Among authors: baldewijns m. Gynecol Oncol Rep. 2019 Feb 15;29:130-131. doi: 10.1016/j.gore.2019.02.005. eCollection 2019 Aug. Gynecol Oncol Rep. 2019. PMID: 31517013 Free PMC article. No abstract available.
Whole-body diffusion-weighted magnetic resonance imaging for the detection of bone metastases and their prognostic impact in metastatic renal cell carcinoma patients treated with angiogenesis inhibitors.
Beuselinck B, Pans S, Bielen J, De Wever L, Noppe N, Vanderschueren G, De Keyzer F, Baldewijns M, Lerut E, Laenen A, Verbiest A, Roussel E, Albersen M, Vandecaveye V. Beuselinck B, et al. Among authors: baldewijns m. Acta Oncol. 2020 Jul;59(7):818-824. doi: 10.1080/0284186X.2020.1750696. Epub 2020 Apr 16. Acta Oncol. 2020. PMID: 32297532
Impact of concomitant acid suppressive therapy on pazopanib efficacy and dose reductions in patients with metastatic renal cell carcinoma.
Van De Sijpe G, Beuselinck B, Van Nieuwenhuyse T, Poncelet R, Bechter O, Albersen M, Roussel E, Baldewijns M, Tack J, Spriet I. Van De Sijpe G, et al. Among authors: baldewijns m. Eur J Clin Pharmacol. 2020 Sep;76(9):1273-1280. doi: 10.1007/s00228-020-02902-3. Epub 2020 May 30. Eur J Clin Pharmacol. 2020. PMID: 32474662
MicroRNA expression profiles in molecular subtypes of clear-cell renal cell carcinoma are associated with clinical outcome and repression of specific mRNA targets.
Verbiest A, Van Hoef V, Rodriguez-Antona C, García-Donas J, Graña-Castro O, Albersen M, Baldewijns M, Laenen A, Roussel E, Schöffski P, Wozniak A, Caruso S, Couchy G, Zucman-Rossi J, Beuselinck B. Verbiest A, et al. Among authors: baldewijns m. PLoS One. 2020 Sep 11;15(9):e0238809. doi: 10.1371/journal.pone.0238809. eCollection 2020. PLoS One. 2020. PMID: 32915890 Free PMC article.
MicroRNAs Possibly Involved in the Development of Bone Metastasis in Clear-Cell Renal Cell Carcinoma.
Kinget L, Roussel E, Lambrechts D, Boeckx B, Vanginderhuysen L, Albersen M, Rodríguez-Antona C, Graña-Castro O, Inglada-Pérez L, Verbiest A, Zucman-Rossi J, Couchy G, Caruso S, Laenen A, Baldewijns M, Beuselinck B. Kinget L, et al. Among authors: baldewijns m. Cancers (Basel). 2021 Mar 28;13(7):1554. doi: 10.3390/cancers13071554. Cancers (Basel). 2021. PMID: 33800656 Free PMC article.
Molecular Subtypes and Gene Expression Signatures as Prognostic Features in Fully Resected Clear Cell Renal Cell Carcinoma: A Tailored Approach to Adjuvant Trials.
Roussel E, Verbiest A, Kinget L, Boeckx B, Zucman-Rossi J, Couchy G, Caruso S, Job S, de Reyniès A, De Wever L, Baldewijns M, Van Poppel H, Joniau S, Lambrechts D, Albersen M, Beuselinck B. Roussel E, et al. Among authors: baldewijns m. Clin Genitourin Cancer. 2021 Dec;19(6):e382-e394. doi: 10.1016/j.clgc.2021.07.005. Epub 2021 Jul 10. Clin Genitourin Cancer. 2021. PMID: 34362692
Overall survival improvement in patients with metastatic clear-cell renal cell carcinoma between 2000 and 2020: a retrospective cohort study.
Demasure S, Spriet I, Debruyne PR, Laenen A, Wynendaele W, Baldewijns M, Dumez H, Clement PM, Wildiers H, Schöffski P, Roussel E, Kinget L, Albersen M, Beuselinck B. Demasure S, et al. Among authors: baldewijns m. Acta Oncol. 2022 Jan;61(1):22-29. doi: 10.1080/0284186X.2021.1989720. Epub 2021 Oct 28. Acta Oncol. 2022. PMID: 34711121
60 results